This insider cluster is too small to be informative. Monitor upcoming pipeline catalysts or earnings for material signals, but this filing has no actionable trading implication.
SEPN drugs
SEPN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 1 $34.61entry
- T+1 · 5mo ago −1.76%α −1.63% · $34.00
- T+5 · 4mo ago +3.52%α +3.26% · $35.83
- T+20 · 4mo ago −2.89%α −0.70% · $33.61
- T+60 · 8w ago +10.17%α +7.30% · $38.13
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Septerna sold a total of $357K in shares over a week, representing a trivial 0.02% of the $1.6B market cap. The sales are routine and non-informative, with no material signal for the stock.
Key Financial Metrics
Key Facts
- Total insider sales of $357K represent ~0.02% of Septerna's $1.6B market cap
- Two insiders sold: SVP Daniel D. Long ($281K) and CPO Samira Shaikhly ($77K)
- Non-cash director grants and derivative exercises also occurred but have $0 economic impact
- Sales are small relative to market cap and likely liquidity-driven (vesting/10b5-1)
Financial Impact
Trivial insider selling of $357K, well below 0.1% of market cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SEPN-1782860533764 |
Track record
25 reports on SEPN
7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $41.86 Now $41.67 −0.45% settles Nov 19
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $41.67 +20.39% settles Nov 17
- Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $41.67 +8.21% ▲ +0.47% +0.69% vs SPY
- Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $41.67 +13.39% ▲ +7.62% +8.83% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers